Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 871 AL 885

Research advances in the microbiota‑gut‑brain axis and Parkinson's disease (Review)

Meng Y, Liu Q, Zou H, Zhu X, Mi X, Li S, Xia Y, Ma Y, Yang Q, Peng J, Li J, Liu X, Chen J.

Mol Med Rep. 2026 Nov;34(5):305. doi: 10.3892/mmr.2026.14016. Epub 2026 Sep 11.

Deep Brain Stimulation after Subthalamic Focused Ultrasound for Parkinson's Disease

Ichise A, Tani N, Ushida Y, Shimizu T, Hosomi K, Oshino S, Kakuda K, Baba K, Kanemoto M, Mochizuki H, Kishima H.

Mov Disord Clin Pract. 2026 Aug 26:10.1002/mdc3.70788. doi: 10.1002/mdc3.70788. Online ahead of print.

Postbiotics as a therapeutic frontier in Parkinson's disease: Insights into molecular pathways and neuroprotective effects

Kumari A, Aran KR.

Metab Brain Dis. 2026 Sep 9;41(1):210. doi: 10.1007/s11011-026-01978-7.

Neurodegenerative Diseases and Sleep Disorders: The Bidirectional Relationship

Desai KM, Thakkar MD, Somaiya TS, Thomas DC.

Med Clin North Am. 2026 Sep;110(5):889-905. doi: 10.1016/j.mcna.2025.12.001. Epub 2026 Apr 21.

Physical Activity and Exercise for People with Parkinson's Disease: The Past, Present, and Future

Corcos DM, Munoz MJ, Mehta N, McKee KE.

Mov Disord. 2026 Aug;41(8):2014-2021. doi: 10.1002/mds.70396. Epub 2026 Jun 14.

Prevalence and related factors of blood pressure regulation abnormalities in Parkinson's disease: Orthostatic hypotension and supine hypertension

Jia J, Zeng J, Gong Y, Zhou H, Zeng X, Zou J.

J Parkinsons Dis. 2026 Sep;16(6):1250-1262. doi: 10.1177/1877718X261457798. Epub 2026 Jun 4.

Gut Microbiota, Neuroinflammation, and Autonomic Dysfunction in Neurodegenerative Diseases: A Systematic Review of Mechanistic and Translational Evidence

Alauddin W, Srivastava C, Goyal P, Shukla M, Garg DK, Prajesh BR, Singh S, Shaikh FI, Khairnar S.

Cureus. 2026 Aug 10;18(8):e114312. doi: 10.7759/cureus.114312. eCollection 2026 Aug.

Hypertension management in the elderly and the very elderly

Guasti L, Derosa G, Fumagalli S, Ferrini M, Asteggiano R.

Eur J Prev Cardiol. 2026 Aug 27;33(Supplement_3):iii44-iii51. doi: 10.1093/eurjpc/zwaf194.

Transplacental Sirolimus Therapy for Severe Fetal Cardiac Rhabdomyomas in Tuberous Sclerosis Complex: Organ-Specific Responses and 30-Month Follow-Up: A Case Report

Naito K, Moriyama Y, Kawai Y, Saito K, Nakajima H, Nakamura M, Sekiya T, Ishihara N, Miyata M, Yoshikawa T, Nishizawa H.

Fetal Diagn Ther. 2026 Sep 1:1. doi: 10.1159/fdt/acuag007. Online ahead of print.

Central Nervous System Tumors in Xeroderma Pigmentosum: Five Cases and Review of the Literature

Bakr FS, Arisoy H, Lehmann AR, Giunti P, Fassihi H.

Mov Disord. 2026 Sep;41(9):2523-2528. doi: 10.1002/mds.70310. Epub 2026 May 22.

Benzothiazole-driven molecular probes and therapeutics for neurodegenerative diseases: focus on amyloid-beta (Aβ), tau, and α-synuclein

Kumar N, Khan I, Singh J, Kumar K, Kushwaha VK, Kumar S, Ojha S, Dash AK, Shankar G.

RSC Med Chem. 2026 Aug 13. doi: 10.1039/d6md00462h. Online ahead of print.

Hyaluronidase-enhanced delivery in gene therapy and regenerative medicine for improved vector, cell, and cargo access

Sewell PE, Jensen C.

Front Drug Deliv. 2026 Sep 3;6:1906950. doi: 10.3389/fddev.2026.1906950. eCollection 2026.

Advances in phytochemical modulation of protein aggregation in neurodegenerative diseases

Kumari N, Anand S.

3 Biotech. 2026 Oct;16(10):416. doi: 10.1007/s13205-026-05046-w. Epub 2026 Sep 8.

Epigenomic Remodeling by Lipid Metabolism: A Cross-Disease Perspective on Cancer and Brain Disorders

Rafique A, Farooq A, Cho CE, Bakovic M.

Genes (Basel). 2026 Sep 17;17(9):1134. doi: 10.3390/genes17091134.

New approach methodologies in neurotherapeutics development

Tamiz AP, Baran SW, Hartung T, Wu WW.

Neurotherapeutics. 2026 Oct;23(6):e01056. doi: 10.1016/j.neurot.2026.e01056. Epub 2026 Sep 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias